Summary
Intercalative binding of the antitumor drugs amonafide and azonafide to the oligonucleotide duplex d(GGCCGGCCGG)·d(CCGGCCGGCC) was compared using molecular dynamics in vacuum with the AMBER force field. A number of reasonable possible binding conformations were obtained, with the azonafide complexes favored over the amonafide complexes in net binding enthalpy. In comparison with amonafide, the larger chromophore of azonafide permits greater DNA distortion and wider side-chain swings, without falling out of the intercalation site. The best model obtained was used for further dynamics on amonafide and azonafide with solvent and counterions present, and again the azonafide complex had a more favorable enthalpy. Furthermore, the enthalpy change on going from solvent into the intercalation site was less unfavorable for azonafide. These results are consistent with the stronger DNA binding of azonafide compared to amonafide, as observed in relative melting transition temperature increases and tumor inhibition in cell cultures.
Similar content being viewed by others
References
Braña, M.F., Sanz, A.M., Castellano, J.M., Roldan, C.M. and Roldan, C., Eur. J. Med. Chem., 16 (1981) 207.
Braña, M.F., Castellano, J.M., Roldan, C.M., Santos, A., Vasquez, D. and Jimenez, A., Cancer Chemother. Pharmacol., 4 (1980) 61.
Weiss, G.R., Burris III, H.A., Eckardt, J.R., Fields, S., O'Rourke, T., Rodriguez, G.I. and Rothenberg, M.L., Cancer Chemother. Biol. Response Modifiers Annu., 15 (1994) 130.
Saez, R., Craig, J., Weiss, G., Havlin, K., Hardy, J., Clark, G., Kuhn, J., Koeller, J. and Von Hoff, D., Proc. ASCO, 7 (1988) 59.
Llombart, M., Poveda, A., Forner, E., Fernandez-Martos, C., Gaspar, C., Munoz, M., Olmos, T., Ruiz, A., Soriano, V., Benavides, A., Martin, M., Schlick, E. and Guillem, V., Invest. New Drugs, 10 (1992) 177.
Allen, S.L., Ratain, M., Korzun, A.H., Duggan, D., Novak, A., Norton, L. and Henderson, I.C., Proc. Am. Assoc. Cancer Res., 32 (1991) 183.
Waring, M.J., Gonzalez, A., Jiminez, A. and Vasquez, D., Nucleic Acids Res., 7 (1979) 217.
Anderson, B.S., Beran, M., Bakic, M., Silberman, L.E., Newman, R.A. and Zwelling, L.A., Cancer Res., 47 (1987) 1040.
Sami, S.M., Dorr, R.T., Alberts, D.S. and Remers, W.A., J. Med. Chem., 36 (1993) 765.
Dorr, R.T., Remers, W.A., Alberts, D.S., Salmon, S.E. and Hersh, E.M., Proc. Am. Assoc. Cancer Res., 34 (1994) 39.
Sami, S.M., Dorr, R.T., Sólyom, A.M., Alberts, D.S. and Remers, W.A., J. Med. Chem., 38 (1995) 983.
Feigon, J., Denny, W.A., Leupin, W.W. and Kearns, D.R., J. Med. Chem., 27 (1984) 450.
Neidle, S., Drugs Exp. Clin. Res., 12 (1986) 455.
Hingerty, B.E., Figuerou, S., Hayden, T.L. and Broyde, S., Biopolymers, 28 (1989) 1195.
Taylor, E.R. and Olson, W.K., Biopolymers, 22 (1983) 2667.
Manning, G.S., Q. Rev. Biophys., 11 (1978) 179.
Barkley, M.D., Thomas, T.J., Maskos, K. and Remers, W.A., Biochemistry, 30 (1991) 4421.
Pearlstein, R.A., Chemlab-II Reference Manual, Molecular Design Ltd., San Leandro, CA, 1985.
Singh, U.C., Weiner, P.L., Caldwell, J. and Kollman, P.A., AMBER 3.0 and QUEST 1.0 Documentation, University of California, San Francisco, CA, 1986.
Weiner, S.J., Kollman, P.A., Case, D., Singh, U.C., Ghio, C., Alagona, G., Profeta, S. and Weiner, P.K., J. Am. Chem. Soc., 106 (1984) 765.
Ferrin, T.E., Huang, C.C., Jarvis, L.E. and Langridge, R., J. Mol. Graphics, 6 (1988) 1.
Ferrin, T.E., Huang, C.C., Jarvis, L.E. and Langridge, R., J. Mol. Graphics, 6 (1988) 13.
Jorgensen, W., Chandrasekhar, T. and Madura, T., J. Chem. Phys., 79 (1983) 926.
Pearlman, D.A., Case, D.A., Caldwell, J.C., Seibel, G.L., Singh, U.C., Weiner, P. and Kollman, P.A., AMBER 4.0 Documentation, University of California, San Francisco, CA, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bear, S., Remers, W.A. Computer simulation of the binding of amonafide and azonafide to DNA. J Computer-Aided Mol Des 10, 165–175 (1996). https://doi.org/10.1007/BF00402824
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00402824